Ironically we haven't lost any sales and it was always reported as a Q2 2023 target for the common list approvals... Not sure how the share price will react, but imo should highlight that we have the right CEO now and with some gusto.
- Forums
- ASX - By Stock
- ADO
- Ann: European RAT Clinical Trial Halted to Refocus Initiatives
Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-21
-
-
- There are more pages in this discussion • 175 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.28M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.0¢ | $12.51K | 612.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1790998 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 32423 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1790998 | 0.020 |
8 | 1727381 | 0.019 |
4 | 468115 | 0.018 |
2 | 64748 | 0.017 |
1 | 420000 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 700616 | 2 |
0.023 | 322844 | 5 |
0.024 | 741966 | 3 |
0.025 | 1118820 | 11 |
0.026 | 291415 | 3 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |